ArticleScientific reports2025
Green synthesis of silver nanoparticles from plant Astragalus fasciculifolius Bioss and evaluating cytotoxic effects on MCF7 human breast cancer cells.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- A berberine-functionalized green silver nanoplatform for combined chemo-photodynamic therapy against breast cancer cells.Nanoscale advances · 2026Article
- Comprehensive scientific insights on plant inspired nano therapeutics as the missing piece of the breast cancer puzzle.Discover nano · 2026Review
- An In Vitro Study on the Efficacy of Green Synthesized Silver Nanoparticles on Surgical Site Infections and Healings.Biomedicines · 2026Article
- Eco-friendly silver nanoparticles from neem extracts: a dual approach to heavy metal sensing and antimicrobial applications.Bioresources and bioprocessing · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Astragalus fasciculifolius Bioss, commonly known as Anzaroot, is a medicinal plant from the Fabaceae family, recognized for its therapeutic properties due to its rich composition of saponins, flavonoids, and polysaccharides. These compounds have been shown to effectively treat heart diseases and inhibit cancer cell growth while also alleviating chemotherapy side effects. Recent research has focused on the green synthesis of silver nanoparticles (AgNPs) from Anzaroot, exploring their potential cytotoxic effects against MCF-7 human breast cancer cells. This study aims to bridge traditional herbal medicine and modern nanotechnology by evaluating the anticancer properties of AgNPs derived from this lesser-explored plant. This study was aimed to assess the cytotoxic effect of Anzaroot and green synthesized AgNPs using aqueous extract of Anzaroot on the MCF-7 cell line. To optimization of AgNPs synthesis, different parameters were evaluated including Anzaroot aqueous extract volumes (1, 2, 3 and 4 ml), silver nitrate solution (AgNO
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.